LONDON (Alliance News) - Pharmaceutical giant GlaxoSmithKline PLC Wednesday said Patrick Vallance, president of pharmaceuticals research and development, purchased 157 shares at a price of 1564.7584 pence per share on July 11, following the re-investment of a dividend.
GlaxoSmithKline shares closed flat at 1,543.50 pence Wednesday.
By Rowena Harris-Doughty; rowenaharrisdoughty@alliancenews.com; @rharrisdoughty
Copyright 2014 Alliance News Limited. All Rights Reserved.